Wikidata entity: Q3294630
C₇H₄ClNO₂ (P274)
Quantities
| P4250 | defined daily dose | 1.5 |
| P2067 | mass | 168.993 |
| P2101 | melting point | 191 |
| P3780 | active ingredient in | ... | Q47521787 (Lorzone) | Lorzone |
| P3780 | active ingredient in | ... | Q47521963 (Parafon Forte DSC) | Parafon Forte DSC |
| P233 | canonical SMILES | String | C1=CC2=C(C=C1Cl)NC(=O)O2 | ??? |
| P366 | has use | ... | Q12140 (medication) | medication |
| P31 | instance of | ... | Q113145171 (type of chemical entity) | type of chemical entity |
| P8026 | LiverTox likelihood score | ... | Q83284157 (LiverTox toxicity likelihood category B) | LiverTox toxicity likelihood category B |
| P2175 | medical condition treated | ... | Q81938 (pain) | pain |
| P2175 | medical condition treated | ... | Q2006818 (muscle cramp) | muscle cramp |
| P2175 | medical condition treated | ... | Q4117658 (inflammatory myopathy) | inflammatory myopathy |
| P2175 | medical condition treated | ... | Q574360 (spasm) | spasm |
| P129 | physically interacts with | ... | Q21119818 (Potassium calcium-activated channel subfamily N member 4) | Potassium calcium-activated channel subfamily N member 4 |
| P5555 | schematic | CommonsMedia | http://commons.wikimedia.org/wiki/Special:FilePath/Chlorzoxazone%20synthesis.png | ??? |
| P279 | subclass of | ... | Q57246582 (1,3-benzoxazole) | 1,3-benzoxazole |
| P2868 | subject has role | ... | Q50430093 (central muscle relaxants) | central muscle relaxants |
| P2275 | World Health Organisation international non-proprietary name | Monolingualtext | chlorzoxazone | ??? |
Why not click here or view trends?
log id: 3267293